Seer Medical
The story of a visionary startup's rapid rise, its critical fall, and the difficult path to a second chance. An analysis of innovation, failure, and the lessons learned in epilepsy diagnostics.
Podcast: Listen to the full story of Seer Medical's journey, from its groundbreaking innovations to its dramatic collapse and rebirth.
The Vision: A Patient-Centric Revolution
Seer Medical was founded in 2017 to address a critical unmet need: making gold-standard epilepsy diagnostics accessible outside of the hospital. This section explores the core technological innovations that fueled its early success and captured the industry's attention.
Seer Home™ System
A long-term (7-10 day) video-EEG-ECG monitoring system for home use, leveraging AI and cloud tech to reduce hospital stays.
Sense Wearable
An award-winning, shower-proof wearable for EEG-ECG monitoring with a 10-day battery, prioritizing patient comfort.
WaterTabs® Adhesive
A proprietary water-soluble, non-toxic electrode adhesive designed to reduce scalp irritation during long-term studies.
By September 2023, Seer had assisted over 15,000 Australians, saving an estimated 246 years of inpatient hospital days.
The Ascent: Ambition Meets Turbulence
Fueled by over $80 million in funding, Seer embarked on an aggressive expansion into Australia and the US. This section visualizes the company's rapid growth and the emerging cracks that signaled underlying instability.
Major Funding Rounds
~1/3
Workforce laid off in 2023 restructuring, a sign of financial strain.
2/3
Of top US neurology centers were using Seer's tech before the recall.
Warning Signs
The rapid scaling masked growing pains: a slower-than-expected US expansion strained finances, a co-founder CEO was dismissed in early 2023 leading to a public lawsuit, and key board members resigned over fears of impending administration.
The Collapse: A Chain Reaction of Failure
In August 2024, a catastrophic product recall triggered a domino effect that led to the company's collapse. This interactive diagram breaks down the sequence of critical failures. Click on each stage to learn more.
The Rebirth: A Second Chance Under New Stewardship
In April 2025, a rescue package led by neurodiagnostics leader Cadwell Industries provided Seer a lifeline. This section explores the details of the revival and the challenging path ahead for the restructured company.
The $40 Million Rescue Package
The Path Forward
- ✓ Strategic Integration: Seer's AI and cloud tech to be integrated into Cadwell Industries' global portfolio.
- ✓ Next-Gen Device: Development of an updated device to address all previous QMS and EMC flaws.
- ✓ US Market Re-entry: Ambitious target to return to the US market by 2026 with an FDA-cleared device.
- ✓ Staff Retention: Nearly all Seer employees retained, preserving critical institutional knowledge.
Indelible Lessons
Seer Medical's journey offers critical insights for the entire medtech industry. Explore the key takeaways on what it takes to navigate the treacherous path from innovation to sustainable success.
Full Report
Dive deeper into the details of Seer Medical's journey with the comprehensive report.
Download Full Report (PDF)Disclaimer: All content on this page was generated by AI, specifically Google's Gemini 2.5 Pro. The information provided is for illustrative purposes only and may not reflect real-world events or data.